Epicure: a European epidemiological study of patients with an advanced or metastatic Urothelial Carcinoma (UC) having progressed to a platinum-based chemotherapy.

BMC Cancer · 2016 · PMC5035464 · PMID 27664126

Europe PMC DOI

hedged sentence

0.0553

closest p · 1.1× alpha

0.0553

boldest claim

The sentences

at the limit of significancep = 0.0553so close (0.05 < p ≤ 0.1)

The multivariate analysis confirmed the association with response to previous chemotherapy ( p = 0.0356) and time to progression ( p = 0.0063), clearly impacting the choice of subsequent treatment; hemoglobin level was at the limit of significance ( p = 0.0553).

also in 326 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.